Preferential recognition of catechol-estrogen modified DNA by circulating autoantibodies in cancer patients

Area of Science:

• Biochemistry
• Molecular Biology
• Cancer Research

Background:

• Catecholestrogens, such as 4-hydroxyestradiol (4-OHE(2)), are suspected contributors to human carcinogenesis.
• The precise mechanisms underlying catecholestrogen-induced carcinogenesis remain largely unestablished.

Purpose of the Study:

• To investigate the DNA-modifying effects of 4-hydroxyestradiol (4-OHE(2)) in combination with nitric oxide (NO).
• To assess the immunogenicity of modified DNA and its potential role in cancer autoantibody detection.

Main Methods:

• pUC 18 plasmid DNA was chemically modified using 4-OHE(2) and NO.
• Characterization of DNA modifications included hyperchromicity, strand breaks, base damage, and altered thermal/structural properties.
• Immunization of experimental animals with modified DNA to generate antibodies.
• Immunochemical detection of oxidative DNA damage in cancer patients' DNA using induced antibodies.

Main Results:

• 4-OHE(2) and NO modification induced significant alterations in DNA structure and integrity.
• Modified DNA proved highly immunogenic, eliciting high-titer antibodies.
• Experimentally induced anti-4-OHE(2)-NO-DNA antibodies preferentially recognized modified DNA over native DNA.
• These antibodies detected oxidative epitopes on DNA isolated from cancer patients, indicating enhanced binding.

Conclusions:

• The study demonstrates that 4-OHE(2)-NO modification induces DNA damage with unique epitopes.
• The findings suggest a link between oxidative stress-induced DNA damage, autoantibody production, and carcinogenesis.
• The induced antibodies show potential as biomarkers for detecting DNA damage in cancer patients.